<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37060396</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1985</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension</Title><ISOAbbreviation>High Blood Press Cardiovasc Prev</ISOAbbreviation></Journal><ArticleTitle>Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>227</StartPage><EndPage>233</EndPage><MedlinePgn>227-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40292-023-00574-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Arterial Hypertension (HT) has been described as a common comorbidity and independent risk factor of short-term outcome in COVID-19 patients. However, data regarding the risk of new-onset HT during the post-acute phase of COVID-19 are scant.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We assess the risk of new-onset HT in COVID-19 survivors within one year from the index infection by a systematic review and meta-analysis of the available data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data were obtained searching MEDLINE and Scopus for all studies published at any time up to February 11, 2023, and reporting the long-term risk of new-onset HT in COVID-19 survivors. Risk data were pooled using the Mantel-Haenszel random effects models with Hazard ratio (HR) as the effect measure with 95% confidence interval (CI). Heterogeneity among studies was assessed using I<sup>2</sup> statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 19,293,346 patients (mean age 54.6 years, 54.6% males) were included in this analysis. Of them, 758,698 survived to COVID-19 infection. Over a mean follow-up of 6.8 months, new-onset HT occurred to 12.7 [95% CI 11.4-13.5] out of 1000 patients survived to COVID-19 infection compared to 8.17 [95% CI 7.34-8.53] out of 1000 control subjects. Pooled analysis revealed that recovered COVID-19 patients presented an increased risk of new-onset HT (HR 1.70, 95% CI 1.46-1.97, p&#x2009;&lt;&#x2009;0.0001, I<sup>2</sup>&#x2009;=&#x2009;78.9%) within seven months. This risk was directly influenced by age (p&#x2009;=&#x2009;0.001), female sex (p&#x2009;=&#x2009;0.03) and cancer (p&#x2009;&lt;&#x2009;0.0001) while an indirect association was observed using the follow-up length as moderator (p&#x2009;&lt;&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that new-onset HT represents an important post-acute COVID-19 sequelae.</AbstractText><CopyrightInformation>&#xa9; 2023. Italian Society of Hypertension.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuin</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4559-1292</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. zuinml@yahoo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Arzignano General Hospital, Vincenza, Italy. zuinml@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigatelli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ospedali Riuniti Padova Sud, Monselice, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilato</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Arzignano General Hospital, Vincenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquetto</LastName><ForeName>Giampaolo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ospedali Riuniti Padova Sud, Monselice, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazza</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Ospedale S. Maria degli Angeli, Adria, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>High Blood Press Cardiovasc Prev</MedlineTA><NlmUniqueID>9421087</NlmUniqueID><ISSNLinking>1120-9879</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>High Blood Press Cardiovasc Prev. 2023 Sep;30(5):485. doi: 10.1007/s40292-023-00597-y</RefSource><PMID Version="1">37634219</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arterial hypertension</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Follow-up</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>None of the Authors have conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37060396</ArticleId><ArticleId IdType="pmc">PMC10105348</ArticleId><ArticleId IdType="doi">10.1007/s40292-023-00574-5</ArticleId><ArticleId IdType="pii">10.1007/s40292-023-00574-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tadic M, Cuspidi C, Grassi G, Mancia G. COVID-19 and arterial hypertension: hypothesis or evidence? J Clin Hypertens. 2020;22:1120&#x2013;6. doi: 10.1111/jch.13925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.13925</ArticleId><ArticleId IdType="pmc">PMC7362072</ArticleId><ArticleId IdType="pubmed">32627330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130:304&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32231171</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A, Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect. 2020;81:e84&#x2013;6. doi: 10.1016/j.jinf.2020.03.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.059</ArticleId><ArticleId IdType="pmc">PMC7151373</ArticleId><ArticleId IdType="pubmed">32283158</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncon L, Zuin M, Zuliani G, Rigatelli G. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. Br J Anaesth. 2020;125:e254&#x2013;5. doi: 10.1016/j.bja.2020.04.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.04.056</ArticleId><ArticleId IdType="pmc">PMC7183951</ArticleId><ArticleId IdType="pubmed">32381262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Barco S, Giannakoulas G, Engelen MM, Hobohm L, Valerio L, Vandenbriele C, Verhamme P, Vanassche T, Konstantinides SV. Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis. 2023 doi: 10.1007/s11239-022-02766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-022-02766-7</ArticleId><ArticleId IdType="pmc">PMC9845812</ArticleId><ArticleId IdType="pubmed">36652137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Roncon L, Pasquetto G, Bilato C. Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis. Heart Fail Rev. 2022 doi: 10.1007/s10741-022-10292-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-022-10292-0</ArticleId><ArticleId IdType="pmc">PMC9792307</ArticleId><ArticleId IdType="pubmed">36572763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M, Rigatelli G, Battisti V, Costola G, Roncon L, Bilato C. Increased risk of acute myocardial infarction after COVID-19 recovery: a systematic review and meta-analysis. Int J Cardiol. 2023;372:138&#x2013;143. doi: 10.1016/j.ijcard.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.12.032</ArticleId><ArticleId IdType="pmc">PMC9755219</ArticleId><ArticleId IdType="pubmed">36535564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Guti&#xe9;rrez-Sacrist&#xe1;n A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L&#x2019;Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M, Consortium for Clinical Characterization of COVID-19 by EHR (4CE) Cai T, South AM, Kohane IS, Weber GM. International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med. 2022;5:81. doi: 10.1038/s41746-022-00623-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-022-00623-8</ArticleId><ArticleId IdType="pmc">PMC9242995</ArticleId><ArticleId IdType="pubmed">35768548</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses (2012). http://www.ohrica/programs/clinical_epidemiology/oxford.asp, Accessed 29 Aug&#xa0;2022.</Citation></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, Ekka-Zohar A, Ben David SS, Lerner U, Bivas-Benita M, Greenfeld S. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisler A, Stirrup O, Pisarev H, Kalda R, Meister T, Suija K, Kolde R, Piirsoo M, Uusk&#xfc;la A. Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study. PLoS ONE. 2022;17:e0278057. doi: 10.1371/journal.pone.0278057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278057</ArticleId><ArticleId IdType="pmc">PMC9683565</ArticleId><ArticleId IdType="pubmed">36417409</ArticleId></ArticleIdList></Reference><Reference><Citation>Colangelo LA, Yano Y, Jacobs DR, Jr, Lloyd-Jones DM. Association of resting heart rate with blood pressure and Incident Hypertension over 30 years in black and white adults: the CARDIA Study. Hypertension. 2020;76:692&#x2013;8. doi: 10.1161/HYPERTENSIONAHA.120.15233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15233</ArticleId><ArticleId IdType="pmc">PMC7430042</ArticleId><ArticleId IdType="pubmed">32783760</ArticleId></ArticleIdList></Reference><Reference><Citation>ladin A, Al Rifai M, Rasool S, et al. The association of resting heart rate and Incident Hypertension: the Henry Ford Hospital Exercise Testing (FIT) project. Am J Hypertens. 2016;29:251&#x2013;7. doi: 10.1093/ajh/hpv095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpv095</ArticleId><ArticleId IdType="pubmed">26112864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu K, Chen Z, Lipscombe LL, Canadian Hypertension Education Program Outcomes Research Taskforce Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008;178:1429&#x2013;35. doi: 10.1503/cmaj.071283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.071283</ArticleId><ArticleId IdType="pmc">PMC2374870</ArticleId><ArticleId IdType="pubmed">18490638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent ST, Schwartz JE, Shimbo D, Overton ET, Burkholder GA, Oparil S, Mugavero MJ, Muntner P. Race and sex differences in ambulatory blood pressure measures among HIV + adults. J Am Soc Hypertens. 2017;11:420&#x2013;427e3. doi: 10.1016/j.jash.2017.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jash.2017.05.002</ArticleId><ArticleId IdType="pmc">PMC5667355</ArticleId><ArticleId IdType="pubmed">28624171</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgari S, Moazzeni SS, Azizi F, Abdi H, Khalili D, Hakemi MS, Hadaegh F. Sex-specific incidence rates and risk factors for hypertension during 13 years of follow-up: the Tehran lipid and glucose study. Glob Heart. 2020;15:29. doi: 10.5334/gh.780.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.780</ArticleId><ArticleId IdType="pmc">PMC7218790</ArticleId><ArticleId IdType="pubmed">32489802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogungbe O, Gilotra NA, Davidson PM. Et alCardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: cross-sectional. studyOpen Heart. 2022;9:e002084.</Citation></Reference><Reference><Citation>Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133:601&#x2013;9. doi: 10.1161/CIRCULATIONAHA.115.017719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.017719</ArticleId><ArticleId IdType="pmc">PMC4741409</ArticleId><ArticleId IdType="pubmed">26858290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, Hoshide S, Mukoyama M, Kario K, Node K, Rakugi H. Long COVID and hypertension-related disorders: a report from the Japanese society of Hypertension Project Team on COVID-19. Hypertens Res. 2022 doi: 10.1038/s41440-022-01145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pmc">PMC9793823</ArticleId><ArticleId IdType="pubmed">36575228</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler Z, Cao Y, Wu E, Faucon S, Mouhat H, Kovacic J, Sabatier M. Counter-regulatory &#x2018;renin-Angiotensin&#x2019; systemBased candidate drugs to treat COVID-19 diseases in SARS-CoV-2-Infected patients. Infect Disord -Drug Targets. 2020;20:407&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32418532</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626&#x2013;38. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang CY, Wang SI, Wei JC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619. doi: 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101619</ArticleId><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzzenenti G, Maloberti A, Giani V, Biolcati M, Leidi F, Monticelli M, Grasso E, Cartella I, Palazzini M, Garatti L, Ughi N, Rossetti C, Epis OM, Giannattasio C, Covid-19 Niguarda Working Group Covid and cardiovascular diseases: direct and indirect damages and future perspective. High Blood Press Cardiovasc Prev. 2021;28:439&#x2013;45. doi: 10.1007/s40292-021-00464-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-021-00464-8</ArticleId><ArticleId IdType="pmc">PMC8233573</ArticleId><ArticleId IdType="pubmed">34173942</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>